Category: Generics Drugs
South America Generics Drugs
-
Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032
... and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032 In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. According ... Read More
-
Pharmaceutical Contract Manufacturing Market by Type of Product Manufactured (API & Intermediates and FDF), Type of API (Originator API and Generic API), API Potency (Low Potent API and High Potent API), Type of FDF (Originator FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large and Very Large Companies) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, Till 2035
... FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large ... Read More
-
Fill Finish Pharmaceutical Contract Manufacturing Market by Type of Fill Finish Service Offered (Aseptic Filling, Blow-Fill-Seal and Terminal Sterilization), Type of FDF (Generic FDF and Originator FDF), API Potency (Low Potent API and High Potent API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World) and Leading Players: Industry Trends and Global Forecasts, Till 2035
... API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North ... Read More
-
2024 Latin America Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... category is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates ... Read More
-
Latin America Generic Drugs Market Report and Forecast 2024-2032
... expected to grow at a CAGR of 7.10% during the forecast period of 2024-2032, driven by the promotion of generic drugs to reduce the financial burden on public healthcare systems. The market is experiencing robust ... Read More
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral ... Read More
-
Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2024-2032
... 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market ... Read More
-
Pharmaceutical Contract Manufacturing (3rd Edition), 2021-2030 Distribution by [A] business segment (API and FDF), [B] type of API (branded and generic), [C] type of FDF (oral solids, parenteral and others), [D] type of packaging form (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle-East and North Africa): Industry Trends and Global Forecasts
... (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, ... Read More
-
BRIC Countries (Brazil, Russia, India, China) Generics Market Summary, Competitive Analysis and Forecast to 2027
... and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are ... Read More
-
Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $139,492.2 million to the global generics ... Read More
-
Brazil Generics Market Summary, Competitive Analysis and Forecast to 2027
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of ... Read More
-
South America Malaria Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)
... & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others) The SAM malaria treatment market is expected to grow from US$ 71.79 ... Read More
-
South & Central America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market ... Read More
-
BRIC Countries (Brazil, Russia, India, China) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the ... Read More
-
Fibromyalgia Treatment Market, by Drug Class (Antidepressants (Milnacipran (Savella and Other Generics), Duloxetine (Cymbalta and Other Generics), and Others), Antiepileptics (Pregabalin (Lyrica and Other Generics), and Others), Muscle Relaxants, Analgesics, and Others (Including Pipeline Drugs)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Fibromyalgia is ... Read More
-
Brazil Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More